Skip to content
The U.S. Food and Drug Administration (FDA) announced yesterday that the Moderna vaccine is now the second fully approved COVID-19 vaccine after Pfizer-BioNTech. Marketed […]
Moderna COVID vaccine given full FDA approval Read More »
Apart from the health crisis directly caused by the disease itself, the COVID-19 pandemic that has been ravaging the world in the last two
COVID impeded routine immunization for millions of children Read More »
Vir Biotechnology has expanded its partnership with the Bill and Melinda Gates Foundation to include antibody research focusing on creating a functional cure for
Gates foundation funds Vir to develop antibody technology against HIV, malaria Read More »
As the number of Omicron infections appears to be past its peak in many U.S. locations, some experts are cautiously suggesting the COVID-19 pandemic
As U.S. nears Omicron peak, global vaccine gap causes fear of new variants Read More »
The Food and Drug Administration (FDA) announced two decisions last week to allow for the use of remdesivir in certain adult and pediatric patients,
FDA approves remdesivir for COVID-19 patients, even before hospitalization Read More »
The U.S. Food and Drug Administration (FDA) issued an order to limit the use of two monoclonal antibody drugs deemed to be ineffective against
FDA limits use of monclonal antibody drugs Read More »
A primary series of one of four approved COVID-19 vaccines offers 50% protection against hospitalization from the Omicron variant, and the protection level rises
WHO: Booster gives 80% protection against Omicron hospitalization Read More »
In response to a study published last week that found nearly 5 million deaths in 2019 were linked to antimicrobial resistance (AMR), scientists are
Scientists call for new market approaches to antimicrobial development Read More »
Antimicrobial resistance (AMR) is already a leading cause of fatalities, and it is threatening to surpass even cancer as a cause of death, according
Studies: AMR killed nearly 5M in 2019, and it’s getting worse Read More »
The proposal by the Centers for Medicare and Medicaid Services (CMS) to limit coverage for the Alzheimer’s drug Aduhelm to patients in clinical trials
Plan to limit Medicare coverage for Alzheimer’s drug Aduhelm draws criticism Read More »
